Supplemental material
Human Vaccines & Immunotherapeutics
Volume 9, 2013 - Issue 12
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC.
Source:
Elsevier BV
Regulatory T cells, tumour immunity and immunotherapy
Source:
Springer Science and Business Media LLC
Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody
Source:
American Society of Hematology
Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
Source:
Ovid Technologies (Wolters Kluwer Health)
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
Source:
Oxford University Press (OUP)
Rapid and strong human CD8 + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
Source:
American Society for Clinical Investigation
Lysis of Prostate Carcinoma Cells by Trifunctional Bispecific Antibodies (αEpCAM × αCD3)
Source:
SAGE Publications
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
Source:
The American Association of Immunologists
Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo
Source:
Springer Nature
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
Source:
Springer Science and Business Media LLC
Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen
Source:
Springer Science and Business Media LLC
Immunomonitoring results of a Phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)
Source:
American Association for Cancer Research (AACR)
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
Source:
Springer Science and Business Media LLC
Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies
Source:
Ferrata Storti Foundation (Haematologica)
A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
Source:
BioMed Central
[T-cells activated with a trifunctional bi-specific antibody in head and neck cancer].
Source:
Georg Thieme Verlag KG
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer
Source:
Wiley
Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.
Source:
American Association for Cancer Research (AACR)
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Source:
Massachusetts Medical Society
Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s
Source:
Rockefeller University Press
Linking provided by
